Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of T790M Mutation Testing in Patient Tissue and Blood With Various Detection Platforms at Hospital Laboratories in Comparison With Central Testing

NCT02991274 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02991274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of T790M Mutation Testing in Patient Tissue and Blood With Various Detection Platforms at Hospital Laboratories in Comparison With Central Testing
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 16, 2017
Completion date
June 29, 2018
Enrollment
897 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic egfr(+) nsclc patients